摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-chloro-2-methoxybenzenecarbothioamide | 361549-00-0

中文名称
——
中文别名
——
英文名称
5-chloro-2-methoxybenzenecarbothioamide
英文别名
5-Chloro-2-methoxybenzothioamide
5-chloro-2-methoxybenzenecarbothioamide化学式
CAS
361549-00-0
化学式
C8H8ClNOS
mdl
——
分子量
201.677
InChiKey
OAGIPFUJVPMWLU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    67.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Novel amide compounds
    申请人:——
    公开号:US20040087798A1
    公开(公告)日:2004-05-06
    A compound of the formula (I): R 1 -A-X-NHCO—Y—R 2 wherein R 1 is heterocyclic group which may have suitable substituents, or phenyl which may have suitable substituents, R 2 is condensed phenyl which may have suitable substituents, phenyl which may have suitable substituents, or thienyl which may have suitable substituents, A is a group of the formula: —(CH 2 ) t —(O) m — or 1 which R 3 and R 4 are each hydrogen or linked together to form imino, R 5 is hydrogen or lower alkyl, t is 0, 1 or 2, p, m and n are each 0 or 1, X is phenylene which may have suitable substituents, or bivalent heterocyclic group containing nitrogen which may have suitable substituents, Y is bond, lower alkylene, or lower alkenylene, and a salt thereof.
    化合物的结构式(I):R1-A-X-NHCO-Y-R2其中R1是杂环基团,可以有合适的取代基,或苯基,可以有合适的取代基,R2是紧缩苯基,可以有合适的取代基,苯基,可以有合适的取代基,或噻吩基,可以有合适的取代基,A是以下式子的基团:—(CH2)t—(O)m—或1其中R3和R4分别是氢或连接在一起形成亚胺,R5是氢或较低的烷基,t为0、1或2,p、m和n均为0或1,X是苯基,可以有合适的取代基,或含有氮的二价杂环基团,可以有合适的取代基,Y是键,较低的烷基,或较低的烯基,以及其盐。
  • NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
    申请人:Shacham Sharon
    公开号:US20110275607A1
    公开(公告)日:2011-11-10
    The invention generally relates to the field of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to new substituted-heterocyclic azole compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, pulmonary fibrosis, hepatic fibrosis, glomerulonephritis, and other renal disorders, and for the treatment of viral infections (both acute and chronic).
    本发明通常涉及核运输调节剂领域,例如CRM1抑制剂,更具体地涉及新的取代杂环唑类化合物,这些化合物的合成和使用以及它们的制药组合物,例如在治疗、调节和/或预防与CRM1活性相关的生理状况方面的用途,例如治疗癌症和其他肿瘤性疾病、炎症性疾病、异常组织生长和纤维化疾病,包括心肌病、肺纤维化、肝纤维化、肾小球肾炎和其他肾脏疾病,以及治疗病毒感染(急性和慢性)。
  • NOVEL AMIDE COMPOUNDS
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:EP1264820A1
    公开(公告)日:2002-12-11
    A compound of the formula (I):         R1-A-X-NHCO-Y-R2    wherein R1 is heterocyclic group which may have suitable substituents, or phenyl which may have suitable substituents, R2 is condensed phenyl which may have suitable substituents, phenyl which may have suitable substituents, or thienyl which may have suitable substituents, A is a group of the formula:         -(CH2)t-(O)m- or in which R3 and R4 are each hydrogen or linked together to form imino, R5 is hydrogen or lower alkyl, t is 0, 1 or 2, p, m and n are each 0 or 1, X is phenylene which may have suitable substituents, or bivalent heterocyclic group containing nitrogen which may have suitable substituents, Y is bond, lower alkylene, or lower alkenylene, and a salt thereof.
    式 (I) 的化合物: R1-A-X-NHCO-Y-R2 其中 R1 是杂环基团,可带有合适的取代基,或苯基,可带有合适的取代基、 R2 是缩合苯基,可具有合适的取代基;苯基,可具有合适的取代基;或噻吩基,可 具有合适的取代基、 A 是式中的一个基团: -(CH2)t-(O)m- 或 其中 R3 和 R4 分别为氢或连接在一起形成亚氨基、 R5 是氢或低级烷基、 t 为 0、1 或 2、 p、m 和 n 均为 0 或 1、 X 是可以有适当取代基的亚苯基,或可以有适当取代基的含氮二价杂环基团、 Y 是键、低级亚烷基或低级亚烯基、 及其盐。
  • OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF
    申请人:TREGA BIOSCIENCES, INC.
    公开号:EP1126833A2
    公开(公告)日:2001-08-29
  • EP1126833A4
    申请人:——
    公开号:EP1126833A4
    公开(公告)日:2004-09-08
查看更多